Versions Compared
Key
- This line was added.
- This line was removed.
- Formatting was changed.
Panel | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
Co-chairs: Brett EslerSafe medication management is a critical clinical safety issue. The HL7 Australia Medication Workgroup (WG) provides a forum for stakeholders and interest parties to contribute and discuss matters related to clinical and technical contents of medication information.
Interested parties/stakeholders from the clinical and technical communities are welcome and encouraged to join and participate in the activities of this WG. As a member of HL7 Medication WG, you will be able to:
|
Note | ||
---|---|---|
| ||
If you have an interest in being co-chair for this working group please contact the Working Group Liaison Officer on email wglo@hl7.org.au to nominate. Ideally each working group will have 2 or more co-chairs. |
Panel | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
ConferencingEXTRA MEETING Friday 22 Mar 2019 12:30-1:30pm Eastern Daylight Savings Time Next meeting Wednesday 1-2pm Eastern Daylight Savings Time (Every 2 Weeks)Join from PC, Mac, Linux, iOS or Android: https://zoom.us/j/8838248492 or Phone: +61 (0) 2 8015 2088, Meeting ID: 883 824 8492 International numbers available: https://zoom.us/zoomconference?m=tiJBLgpQ1Jwgz8W6fYSFjBfO0TXzS_yE notifications email list - sign in with google account or register you email with google id to join: https://groups.google.com/a/hl7.org.au/forum/?hl=en#!forum/medications-working-group |
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
|
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Draft/Discussions/Minutes: Here on Confluence (see the navigation at the left) Discussions: Please refer to the FHIR discussion forums at https://chat.fhir.org/#narrow/stream/australia Technical Artifacts: FHIR Implementation Guide artifacts can be found at http://hl7.org.au/fhir |
Panel | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||
|
...